G Q3 Earnings Beat Estimates on ATS Growth, Margins Expand

Genpact’s Q3 2026 adjusted EPS rose 10.3% year over year to $1.07, beating the $1.05 consensus, while revenue increased 7.3% to $1.39 billion. ATS revenue surged 30.3% to $405.1 million, and gross margin expanded 160 basis points to 38%; the company raised its 2026 gross-margin outlook to 36.9% from 36.5% and adjusted EPS guidance to $4.14 from $4.09. Results were tempered by flat Core Business Services revenue and first-nine-month operating cash flow of $142 million versus $526.2 million a year earlier, including a $405.8 million increase in accounts receivable.

Analysis

The investable signal is mix quality, not the modest quarterly beat: shifting toward non-headcount and outcome-based work could weaken the traditional link between revenue growth and labor costs, supporting durable gross-margin improvement if delivery economics hold. That creates a competitive threat to labor-arbitrage-heavy providers and raises the bar for Accenture, Cognizant and Infosys to demonstrate monetizable AI workflows—not merely AI-related bookings.

The counterweight is conversion risk. Agentic contract value is a leading indicator, not recognized revenue; fixed-fee and outcome-based delivery also transfer execution and service-level risk to Genpact. The sharp receivables build and weaker year-to-date operating cash generation make cash conversion the near-term test, especially alongside higher SG&A. A better EPS outlook without sustained cash flow could prove lower quality than the margin narrative implies.

Days: a small beat and limited guidance uplift may cap the immediate re-rating. Over 1–3 months, watch bookings conversion, receivable days and cash from operations. Over 6–18 months, successful automation could expand margins while cannibalizing legacy headcount-based revenue; failure to convert pilots/contracts would expose the growth premium. The contrarian angle is that investors may underappreciate the structural mix improvement, but could overvalue TCV before revenue and cash realization. No valuation or price data is supplied, so conviction does not justify chasing.

Key Decisions for Investors

• G: Prefer a staged, modest long only on weakness or after confirming improving cash conversion; do not pay up solely for agentic TCV. Reassess if receivables continue to outgrow revenue or operating cash flow fails to recover.
• Track quarterly ATS growth alongside recognized revenue, gross margin and client conversion—not contract value alone. A slowdown in ATS growth or reversal in margin expansion would falsify the mix-shift thesis.
• Treat the working-capital outflow as an alert, not yet proof of deterioration: verify receivable days, aging and subsequent collections. Persistent deterioration would outweigh incremental EPS guidance and argue for reducing exposure.
• Relative-value watch: favor providers that can show repeatable AI-enabled productivity and outcome-based revenue over labor-intensive outsourcing models; avoid a named pair trade until peer valuation and growth data are verified.